News and Insights

Partner Neil Barofsky Testifies Before Senate Judiciary Committee on Historic Credit Suisse Investigation

Last month, Partner Neil Barofsky testified before the US Senate Judiciary Committee to present findings from the ongoing investigation into Credit Suisse's historical ties to Nazi-era clients. His testimony, which included a 75-page written statement, revealed previously unreported relationships between the bank and Nazi-era entities....READ MORE

Jenner & Block Secures Reversal of Preliminary Injunction in High-Stakes Pharmaceutical Battle

In a significant victory for pharmaceutical competition and access to generic drugs, Jenner & Block secured a key litigation win on behalf of client MSN Pharmaceuticals. A federal judge denied a pharmaceutical company’s request for injunctive relief, removing an obstacle to MSN’s planned launch of a generic version of Entresto, a widely used heart failure medication....READ MORE

Navigating the Hazards of US Litigation: Lessons from Recent Decisions Involving Korean Companies

Notwithstanding recent political turmoil, Korean companies have been expanding into the United States at a fast clip, continuing a trend of investment beneficial to businesses in both countries.1 As Korean brands increasingly become players in the US market, however, these companies also face new risks of litigation in US courtrooms. Three recent cases involving Korean companies highlight the types of legal issues that might arise when doing business in the United States and offer valuable lesso...READ MORE